Cytokinetics | CYTK - Equity Capital And Reserves



Cytokinetics reported $-737440000 in Equity Capital and Reserves for its fiscal quarter ending in June of 2025.


Equity Capital And Reserves Change Date
Acadia Pharmaceuticals USD 822.38M 57.14M Jun/2025
Amgen USD 7.43B 1.22B Jun/2025
Bayer EUR 30.5B 2.08B Jun/2025
Biogen USD 17.63B 655.3M Jun/2025
Bristol-Myers Squibb USD 17.49B 100M Jun/2025
Cytokinetics USD -737440000 471.03M Jun/2025
Eisai JPY 828.51B 12.91B Jun/2025
Eli Lilly USD 18.27B 2.43B Jun/2025
Exelixis USD 2.03B 97.49M Jul/2025
Geron USD 259.53M 8.71M Jun/2025
Halozyme Therapeutics USD 332.75M 149.52M Jun/2025
Ionis Pharmaceuticals USD 631.72M 156M Jun/2025
Ligand Pharmaceuticals USD 828.53M 32.99M Jun/2025
Merck USD 49.06B 725M Jun/2025
Novartis USD 42.05B 3.6B Jun/2025
Pfizer USD 88.7B 1.64B Jun/2025
Regeneron Pharmaceuticals USD 29.94B 551.3M Jun/2025
Roche Holding CHF 36.16B 3.28B Dec/2024
Sanofi 70.28B 3.8B Jun/2025